Trial Details
RecruitingBasic Information
| Clinical ID | c3110 |
|---|---|
| Identifier | NCT02044952 |
| Trial Title | Prospective Experimental of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory Bowel Diseases;Crohn's Disease;Gastrointestinal Diseases;Digestive System Diseases;Intestinal Diseases |
| Interventions | Drug: Mesalazine, Tripterygium glycosides |
Participant Information
| Sponsor | Zhu Weiming |
|---|---|
| City | - |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |